Zeotech (ASX:ZEO) announced the launch of an on-site validation trial of its methane emissions control technology at a North Burnett Regional Council landfill, following a research agreement with Griffith University.
The trial marks the next step in commercialising Zeotech's Methane Control Program, building on successful simulated landfill trials in 2025 where its zeoteCH₄ biofilter reduced methane emissions by more than 90%.
The six-month program will test the biofilter under real-world conditions, collecting over 800 data points to assess performance and optimise oxidation rates.
Zeotech CEO James Marsh highlighted the strategic alignment with the company's Toondoon Kaolin Project and the potential for a low-cost, scalable solution for rural and regional landfills, many of which lack gas collection infrastructure.
Griffith University's Dr Chris Pratt, who has led the research since 2023, described the trial as a crucial step in validating the technology at operational scale, with the potential to contribute significantly to Australia’s emissions reduction targets.
Zeotech has also secured provisional and international patent protection for the technology, strengthening its intellectual property position and commercial prospects.
At the time of reporting, Zeotech's share price was $0.084.